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A B S T R A C T
Bacillus anthracis, the etiological agent of anthrax, procures its particular virulence by a capsule and two AB type
toxins: the lethal factor LF and the edema factor EF. These toxins primarily disable immune cells. Both toxins are
translocated to the host cell by the adhesin-internalin subunit called protective antigen PA. PA enables LF to
reach intra-luminal vesicles, where it remains active for long periods. Subsequently, LF translocates to non-
infected cells, leading to ineﬃcient late therapy of anthrax. B. anthracis undergoes slow evolution because it
alternates between vegetative and long spore phases. Full genome sequence analysis of a large number of
worldwide strains resulted in a robust evolutionary reconstruction of this bacterium, showing that B. anthracis is
split in three main clades: A, B and C. Clade A eﬃciently disseminated worldwide underpinned by human
activities including heavy intercontinental trade of goat and sheep hair. Subclade A.Br.WNA, which is wide-
spread in the Northern American continent, is estimated to have split from clade A reaching the Northern
American continent in the late Pleistocene epoch via the former Bering Land Bridge and further spread from
Northwest southwards. An alternative hypothesis is that subclade A.Br.WNA. evolved from clade A.Br.TEA
tracing it back to strains from Northern France that were assumingly dispatched by European explorers that
settled along the St. Lawrence River. Clade B established mostly in Europe along the alpine axis where it evolved
in association with local cattle breeds and hence displays speciﬁc geographic subclusters. Sequencing technol-
ogies are also used for forensic applications to trace unintended or criminal acts of release of B. anthracis. Under
natural conditions, B. anthracis generally aﬀects domesticated and wild ruminants in arid ecosystems. The more
recently discovered B. cereus biovar anthracis spreads in tropical forests, where it threatens particularly en-
dangered primate populations.
1. Introduction
Bacillus anthracis is a spore forming Gram-positive bacterium
causing anthrax. It has a long history as a life threatening infectious
agent of humans and animals worldwide (Turnbull, 2002). However,
active control measures, particularly strict prohibition of burial of
carcasses and slaughter waste as well as large animal vaccination pro-
grams during the ﬁrst part of the 20th century, signiﬁcantly reduced the
incidence of anthrax in many industrialized areas. Anthrax is poten-
tially infectious to most mammals. However, it primarily aﬀects rumi-
nants since they are most frequently exposed to the pathogen in the
environment. This bacterium survives for decades as spores on mea-
dows contaminated by abandoned or buried carcasses of antecedently
succumbed animals. Humans generally acquire anthrax by contact with
infected animals or from occupational or nutritional exposure to con-
taminated animal products such as meat, hair or skin (Pilo and Frey,
2011; WHO, 1998). In humans, the clinical manifestation is dependent
upon the route of infection. Three major forms are described: the cu-
taneous, the gastro-intestinal and the pulmonary form (WHO, 1998).
Lately, injectional anthrax (IA) was observed in patients after injection
of drug contaminated with B. anthracis spores (Hanczaruk et al., 2014;
Ringertz et al., 2000).
B. anthracis belongs to the B. cereus sensu lato group (Okinaka and
Keim, 2016). Species included in this group are distinguished by phe-
notypic diﬀerences, host species predilection, clinical manifestation and
ecological niches. However, old molecular typing methods did not
allow to clearly distinguish them suggesting to consider them as a
“single species” (Helgason et al., 2000). Subsequently, analyses of the
gene ﬂow across the B. cereus sensu lato group revealed that B. anthracis
is clonal and, discerning from the other species (Didelot et al., 2009). In
clinical settings, the identiﬁcation of B. anthracis is based on phenotypic
and genotypic characteristics. B. anthracis is sensitive to penicillin,
phage γ and produces a capsule (WHO, 2008). However, unusual
virulent strains that cause anthrax but showing phenotypic traits of B.
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cereus have been isolated. These strains make the classic identiﬁcation
of the etiological agent of anthrax more diﬃcult (Hoﬀmaster et al.,
2006; Hoﬀmaster et al., 2004; Irenge and Gala, 2012; Klee et al., 2010;
Leendertz et al., 2006; Marston et al., 2016; WHO, 2008; Wright et al.,
2011). Virulence of B. anthracis is determined by two virulence plas-
mids, pXO1 and pXO2, that can be targeted by speciﬁc PCRs. The
plasmid pXO1 encodes for two binary toxins: the lethal factor (LF) and
the edema factor (EF) and an adhesion subunit termed the protective
antigen (PA) that is common to both lethal factor and edema factor.
Plasmid pXO2 carries an operon, capBCDAE, for the production of a
poly-γ-D-glutamic acid capsule (Fig. 1).
B. anthracis has the peculiar biological feature to alternate between
a vegetative phase and a spore phase. In the environment, B. anthracis
occurs principally as spores where it is metabolically dormant and does
not replicate over long periods. Once the spores are taken up by the
host, they germinate and vegetative cells multiply in the host. Within
the host, B. anthracis is able to avoid clearing by the immune system
thanks to its toxins and capsule. Under these conditions, replication
lasts for a relatively short period of 20–40 generations until the death of
the host or clearance of vegetative bacteria by therapeutic agents (Keim
et al., 2004). Exceptionally, B. anthracis can grow in rich soil but tends
to lose the virulence plasmid pXO2, indicating that this virulence at-
tribute not only grants the ability to infect mammals but also confers
species host restriction (Saile and Koehler, 2006). In contrast to most
other bacteria with similar generation times, B. anthracis evolves very
slowly due to the long dormant periods as spores. Due to this slow
evolution and the lack of lateral gene transfer, B. anthracis is genetically
and phenotypically highly homogeneous. Hence, individual strains or
isolates cannot be subtyped by old methods such as serotyping, bio-
chemical reactions or phage typing. However, recently developed rapid
sequencing methods have resulted in the availability of full genome
sequences of hundreds of B. anthracis strains. These data allow the
identiﬁcation of single strains of B. anthracis in outbreak investigations
and forensic settings and give a constantly improving and detailed
picture of the population genetics of B. anthracis around the world.
2. Taxonomy
B. anthracis belongs to the phylum Firmicutes, the family Bacillaceae,
the genus Bacillus and the Bacillus cereus group. The latter consists of six
members: B. anthracis, B. cereus, B. mycoides, B. pseudomycoides, B.
thuringiensis, B. weihenstephanensis and B. cytotoxicus (Guinebretiere
et al., 2013; Okinaka and Keim, 2016). These species are closely related
and have been traditionally identiﬁed based on phenotypic character-
istics, pathogenicity, clinical symptoms, host preference and ecological
niche (Rasko et al., 2005). Most of these species are of economic, en-
vironmental, medical and biodefence importance. The chromosomes of
the diﬀerent members of the B. cereus group show a high level of
Fig. 1. Overview of the molecular mechanisms of virulence of Bacillus anthracis.
B. anthracis (upper left) synthesizes the 4 major virulence factors: the lethal toxin zinc metalloprotease (LF), the edema factor calmodulin-dependent adenylate
cyclase (EF) and the adhesive subunit of the two toxins named ‘protective antigen’ (PA) all of which are encoded on plasmid pXO1, and the poly-D-glutamic acid
polymer capsule (CAP) that allows survival of the bacterium in macrophages encoded on plasmid pXO2. PA binds to the receptors on the host cell, CMG2 and TEM8,
and is subsequently cleaved by furin, allowing multimerization and binding of LF or EF. The PA:EF and PA:LF complexes are then internalized by endocytosis in a
dynamine-clathrin dependent way. In the acid environment of the endosomes, the PA:EF and PA:LF complexes change conformation in order to dissolve the
complexes, transit to late endosomes and release the toxic subunits, which exert their activities by overproduction of cAMP by EF and apoptosis, release of pro-
inﬂammatory cytokines subsequent shock by proteolytic cleavage of MAPKK by LF. Part of the toxins remain in intra-luminal vesicles that are able to transfer as
exosomes and to be incorporated to non-infected cells, where the toxins can be stored for long term, release and exert their activity long after the infection has taken
place. Abbreviations: CAP, capsule; PA, protective antigen; EF, edema factor; LF, lethal factor; VNTR, variable number tandem repeat; MAPKK mitogen-activated
protein kinase kinase; CaM, calmodulin; cAMP, cyclic adenosine 3′ 5′ mono phosphate; CMG2, capillary morphogenesis gene 2. Figure adapted from (Pilo and Frey,
2011).
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synteny and protein similarity with little diﬀerence in gene content
(Okinaka and Keim, 2016; Rasko et al., 2005). The main virulence at-
tributes of the species of the B. cereus group are host speciﬁc toxins and
capsular carbohydrates that allow bacteria to avoid clearance by the
host's immune defence. They are generally encoded on plasmids, and
deﬁne host speciﬁcity and consequently delineate the bacterial species.
The identiﬁcation of individual species of the B. cereus group is there-
fore complex, and some isolates display unusual biochemical and/or
physiological properties that confound their accurate diﬀerentiation
(Klee et al., 2006; Beesley et al., 2010). Phylogenetically, the B. cereus
group of bacteria is divided into 3 distinct clades that show partial
barriers to inter-clade gene ﬂow. Strains of B. anthracis that are highly
clonal are restricted to clade 1 together with the highly virulent emetic
toxin (cereluid synthethase) producing B. cereus strains. Other virulent
B. cereus strains and the insect pathogen B. thuringiensis are found in
clade 2. Clade 3 contains environmental, mostly non-pathogenic B.
cereus, B. mycoides and B. weihenstephanensis. (Priest et al., 2004; Ko
et al., 2004; Helgason et al., 2004; Didelot et al., 2009). The recently
described species B. cytotoxicus seems to form a new clade as identiﬁed
by 16S rRNA gene sequence based phylogeny (Guinebretiere et al.,
2013; Okinaka and Keim, 2016).
B. anthracis can be identiﬁed using a battery of speciﬁc bacter-
iological tests that examine colony morphology, capsule staining, lack
of hemolysis, sensitivity to γ-phage, sensitivity to penicillin and motility
(WHO, 1998). Nevertheless, some strains may show variability in terms
of phenotype, complicating the exact identiﬁcation and diﬀerentiation
between B. anthracis and other types of B. cereus, although these two
species show diﬀerent pathological manifestations (Klee et al., 2006;
Beesley et al., 2010). Nonetheless, strains with characteristics of B.
cereus have been isolated from animals with clinical anthrax
(Antonation et al., 2016; Hoﬀmann et al., 2017; Hoﬀmaster et al., 2006;
Hoﬀmaster et al., 2004; Klee et al., 2006; Pilo et al., 2011). Hence,
several established genetic markers for B. anthracis, such as the chro-
mosomal locus Ba813 (Patra et al., 1996) or the gene sap encoding the
S-layer protein (Ryu et al., 2003) can result in ambiguous diagnostic
identiﬁcation of B. anthracis (Ramisse et al., 1999).
The key virulence determinants that diﬀerentiate pathogenic spe-
cies of the B. cereus group in their pathogenicity and host speciﬁcity
represent relatively small portions of their genomes. These genome
segments are harbored by mobile elements and were likely acquired by
gene transfer from other species rather than evolved by adaptation in
their respective hosts. Virulence of B. anthracis is determined by two
plasmids named pXO1 (toxin plasmid) and pXO2 (capsule plasmid)
(Fig. 1). Under certain circumstances, these plasmids can be transferred
among related species, particularly among B. cereus clade 1 or are found
in this clade as similar plasmids (Didelot et al., 2009; Hoﬀmaster et al.,
2004; Hu et al., 2009; Klee et al., 2006; Ruhfel et al., 1984).
3. Mechanisms of pathogenicity
The main virulence factors of the vegetative form of B. anthracis are
the poly-γ-D-glutamic acid capsule and the tripartite anthrax-toxin. The
poly-γ-D-glutamic acid capsule encoded on the virulence plasmid pXO2
is of low immunogenicity and confers resistance against phagocytosis
and the complement system, rendering the infectious agent invulner-
able to the host's immune system (Makino et al., 2002).
The tripartite toxin is composed of two AB–type toxins. The ﬁrst one
is composed of the adhesion subunit ‘protective antigen’ PA plus the
lethal toxin subunit LF, a metalloprotease. The second consists of PA
plus the edema toxin subunit EF, a highly eﬃcient calmodulin-depen-
dent adenylyl cyclase (Fig. 1). In order to exert their toxic biochemical
activities at the targets, the toxins need to gain access to the cell cy-
toplasm. This task is performed by hijacking cellular pathways with the
help of two main receptors that are recognized by PA: the capillary
morphogenesis genes 2 product (CMG2 or ANTXR2) and the tumor
endothelial marker 8 (TEM8 or ANTXR1) (Bradley et al., 2001; Scobie
et al., 2003). Both are integrin like proteins that bind to the extra-
cellular matrix proteins such as collagens and ﬁbronectin and have a
van Willebrand factor A domain, an Ig-like domain plus a helical trans
membrane domain (Deuquet et al., 2012). Knockout-mice deleted for
the CMG2 gene are fully resistant to anthrax toxin challenge indicating
that CMG2 is the main receptor for the anthrax toxins (Liu et al., 2012).
Once PA is bound to the receptors at the host cell surface, the 83 kDa PA
is cleaved by a host furin-like protease to produce a shorter 63 kDa form
that assembles into heptamers or octamers in membrane lipid rafts to
which LF and EF can bind (Abrami et al., 2003) (Fig. 1). The complexes
PA:LF and PA:EF are internalized by dynamin-clathrin-mediated en-
docytosis (Abrami et al., 2010). After internalization from the cell
surface PA undergoes a conformational change triggered by the acidic
(H+) environment in endosomes forming pores to translocate the en-
zymatic subunits EF and LF to the cytoplasm where they exert their
toxic activity, or to an intermediary state in intraluminal vesicles. In the
cytoplasm LF, the zinc dependent metalloprotease, inactivates members
of the MAPKK kinase family (MEK) by proteolytic cleavage which leads
to excessive release of cytokines, apoptosis, and ﬁnally to necrosis and
hypoxia (Duesbery et al., 1998).
The edema factor EF, which reaches the same compartments as LF
using PA (Fig. 1), is a highly eﬃcient calmodulin-dependent adenylyl
cyclase that is about 1000 times more active than mammalian adenylyl
cyclase to convert ATP to c-AMP. At high concentrations, c-AMP results
in the decrease of chloride ions and a strongly increased water eﬄux
from the aﬀected cells (Drum et al., 2000). This leads to massive edema
that is typical in cutaneous anthrax.
In the initial phases of the infection, both LF and EF target and
disable myeloid cells, such as macrophages and neutrophils, blocking
the host's immune system and allowing the infection to progress to an
acute state with fever, sore throat, diarrhea and vomiting. The later
stages of anthrax are favored by the fact that the toxins that have
reached intraluminal vesicles remain protected from lysosomal en-
zymes, hence allowing long-term storage of the potent active toxins
(Abrami et al., 2013) (Fig. 1). This long-term storage of active enzymes
in intraluminal vesicles and their long lasting release that is possible
even in absence of bacteria are important characteristic of the high
virulence of B. anthracis. It seems to be the reason why patients even
after successful elimination of bacteria by treatment with antibiotics
still succumb to the disease dying from a systemic infection when
treatment is administrated too late (Abrami et al., 2013).
4. Molecular typing methods
Bacterial genomes are dynamic. Numerous molecular mechanisms
shape the evolution of bacteria and various genetic processes generate
genomic diversity. They are mainly based on acquisition or loss of
genes, genome rearrangements and accumulation of mutations ap-
pearing during DNA replication resulting in the genomic heterogeneity
of bacterial populations (Davis and Isberg, 2016; Fraser-Liggett, 2005).
At the level of strains, genomic variations can lead to speciﬁc pheno-
typic traits. Initially, typing of bacterial strains was tested phenotypi-
cally but molecular technics were rapidly included in the panel of
possibilities to distinguish strains (Li et al., 2009). In the last decades,
improvements achieved in DNA sequencing technologies and the de-
velopment of bioinformatics tools to analyze data revolutionized in-
vestigations of intra-species diversity, even for genetically homo-
geneous species like Yersinia pestis, Salmonella enterica Typhi,
Mycobacterium leprae and Bacillus anthracis (Benjak et al., 2018;
Bochkareva et al., 2018; Fournier et al., 2014; Holt et al., 2008;
Schuenemann et al., 2018; Van Ert et al., 2007). Nowadays, genomic
characterization of strains is applied beyond clinical bacteriology and
epidemiology in ﬁelds such as vaccine design (Cafardi et al., 2013),
food industry (Douillard and de Vos, 2014) and forensic science
(Gonzalez et al., 2017).
Early attempts to type B. anthracis strains were hampered because
P. Pilo, J. Frey Infection, Genetics and Evolution 64 (2018) 115–125
117
this bacterium is genetically very homogeneous and underwent clonal
evolution compared to the other species belonging to the B. cereus sensu
lato group (Ehling-Schulz et al., 2005; Keim et al., 2000). Common
genetic tools to diﬀerentiate bacterial strains were not adequate for this
species (Harrell et al., 1995) before the advent of high-throughput DNA
sequencing methods. Typing schemes based on Variable Number
Tandem Repeats (VNTR) provided the ﬁrst step in distinguishing in-
dividual B. anthracis strains, initially using the repeats in the gene
named variable region with repetitive sequence vrrA (Andersen et al.,
1996; Henderson et al., 1995). Additional tandem repeats were subse-
quently identiﬁed leading to the development of a protocol to perform
multiple-locus VNTR analysis (MLVA) (Keim et al., 1997; Keim et al.,
1999; Keim et al., 2000). The assay was initially developed for eight
markers (MLVA8): six chromosomal (vrrA, vrrB1, vrrB2, vrrC1, vrrC2
and CG3) and two plasmidic markers (pXO1-aat and pXO2-at). Suc-
cessively, supplementary markers were identiﬁed and the MLVA
scheme was extended to MLVA15 (MLVA8 markers plus Bavntr12,
Bavntr16, Bavntr17, Bavntr19, Bavntr23, Bavntr32, Bavntr35) (Van Ert
et al., 2007), MLVA20 (Le Fleche et al., 2001) and MLVA25 (Lista et al.,
2006). All described VNTR markers were lately merged resulting in
MLVA31 (Beyer et al., 2012; Braun et al., 2015; Grunow et al., 2013;
Rume et al., 2016; Thierry et al., 2014). An additional protocol using 22
single nucleotide repeat (SNR) markers to achieve higher resolution
that might be required for epidemiological studies was described
(Keneﬁc et al., 2008a; Stratilo and Bader, 2012; Stratilo et al., 2006).
MLVA allows high resolution for typing strains (Keim et al., 2004).
However, this method is prone to homoplasy and thus interferes with
phylogenetic studies (Keim et al., 2004). Reverse mutations causing
homoplasy are more likely to occur in VNTR loci with lower diversity,
due to the structure of the repeats that cause a higher error rate by
polymerases and to the fact that many VNTRs are not in coding or
regulatory sequences and therefore are not subject to selective pressure
(Reyes et al., 2012). Furthermore, it must be taken into account that
VNTR analysis techniques can cause homoplasy problems in PCR-based
assays that strongly aﬀect the inference of recent population history
(Wan et al., 2004). VNTR-based methods are hence limited for appli-
cations that strongly rely on evolutionary interference such as epide-
miological and forensic studies.
High-throughput DNA sequencing methods improved whole
genome sequencing (WGS) and the detection of single nucleotide
polymorphisms (SNPs) (Pearson et al., 2004). WGS of a large number of
B. anthracis strains showed that SNPs are evolutionary stable. Thus
Fig. 2. Schematic tree summarizing the nomenclature based on canSNPs of B. anthracis. The three major lineages of B. anthracis, A, B and C, are shown in bold
capital letters. The canSNPs are shown in red. Branch lengths are not scaled. Data adapted from (Sahl et al., 2016). (For interpretation of the references to colour in
this ﬁgure legend, the reader is referred to the web version of this article.)
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representative non-homoplastic SNPs, named canonical SNPs
(canSNPs), were selected allowing branch points and clades to be ac-
curately deﬁned for phylogenetic studies. A worldwide collection of
1033 strains of B. anthracis was tested with a set of 13 canSNP markers.
The strains could be allocated to three major lineages: A, B and C.
Within these lineages, 12 sublineages / subgroups (lineage A: A.Br.001/
002, A.Br.Ames, A.Br.Aust94, A.Br.003/004, A.Br.Vollum, A.Br.005/
006 [=Ancient A], A.Br.008/009 [=Transeurasian: TEA], A.Br.WNA
[=Western North American], B: B.Br.Kruger, B.Br.001/002,
B.Br.CNEVA and lineage C: C.Br.A1055) were identiﬁed (Van Ert et al.,
2007). A supplementary canSNP was later identiﬁed dividing the group
A.Br.008/009 in A.Br.008/011 and A.Br.011/009 (Marston et al.,
2011). These studies also delineated the ﬁrst comprehensive and sig-
niﬁcant phylogeographical distribution of B. anthracis strains.
The number of samples and their diversity are crucial to achieve the
most precise representation of phylogenetic trees and geographical
distribution. Numerous national collections of B. anthracis strains were
tested by canSNP typing and/or MLVA (Aikembayev et al., 2010;
Antwerpen et al., 2011; Derzelle et al., 2011; Mao et al., 2016; Pilo
et al., 2008; Simonson et al., 2009). Selected strains from those col-
lections were fully sequenced and led to the identiﬁcation of additional
canSNPs (Derzelle et al., 2016a; Rume et al., 2016) and to better un-
derstand the evolution and distribution of B. anthracis strains, such as
the A.Br.Ames lineage (Keneﬁc et al., 2008b) and the A.Br.WNA lineage
(Keneﬁc et al., 2009). The discovery of new canSNPs leads to a ﬁner
resolution of phylogenetic trees by adding new branches resulting in
the splitting of existing clades into subclades of existing clades.
In order to circumvent phylogenetic discovery bias, a nested hier-
archical ﬁngerprinting called progressive hierarchical resolving assays
using nucleic acids (PHRANA), based on the progressive analysis of
VNTRs including SNRs (Keneﬁc et al., 2008a; Stratilo et al., 2006) and
canSNPs (Keim et al., 2004; Van Ert et al., 2007) was developed.
PHRANA allowed higher typing resolution of strains. However,
PHRANA is now mostly replaced by whole genome SNP analysis that
provides full and high resolution among isolates.
5. Phylogeography, population structure and dissemination of B.
anthracis
The phylogenetic structure of B. anthracis was recently deﬁned more
precisely (Sahl et al., 2016). For clarity purposes, new and old desig-
nations of clusters and subclusters are mentioned. In the current state of
knowledge, B. anthracis is divided in 3 major clades: A, B and C (Fig. 2).
Clade A is broadly dispersed throughout the world, while clades B and C
seem to display a narrower geographical distribution (Sahl et al., 2016;
Van Ert et al., 2007; Vergnaud et al., 2016). Although clade A is the
most dispersed branch across the world, subgroups show particular
geographical patterns. The clade A is subdivided in four monophyletic
subclades: A.Br.005/006 (Ancient A, A.Br.034), A.Br.Vollum
(A.Br.005/010, A.Br.047), A.Br.010/008 (A.Br.004) and A.Br.010/004
(A.Br.TEA, A.Br.008) (Fig. 2). Group A.Br.005/006 is basal to the other
subclades and contains strains isolated in Africa (Girault et al., 2014;
Hang'Ombe et al., 2012; Ohnishi et al., 2014; Sahl et al., 2016). A.Br.
Vollum (A.Br.005/010 or A.Br. 047) is most widely dispersed geo-
graphically. A.Br.Vollum seems to be dominant in Pakistan and Af-
ghanistan but it is also found in Western China (Derzelle et al., 2016a;
Price et al., 2012). A.Br.Vollum strains were frequently isolated (and
are still occasionally) from wool factories in Europe and Northern
America and also other parts of the world, assumingly imported via
contaminated raw wool from the area Northern Pakistan – Afghanistan
(Aikembayev et al., 2010; Derzelle et al., 2015; Khmaladze et al., 2014;
Pilo et al., 2008; Van Ert et al., 2007; Wattiau et al., 2008).
Subclade A.Br.008 (A.Br.TEA) is highly prevalent in China and
widely spread across Asia and Europe. In Europe, A.Br.TEA is present
together with the ‘European’ cluster B.Br.004. (B.Br.CNEVA) and sub-
group A.Br.Sterne. Sublineage A.Br.014 (A.Br.Aust94) is spread in
Western China, Turkey and India, while A.Br.081 (A.Br.Ames) is more
prevalent in Eastern and Central China. A.Br.034 (A.Br.005/006,
Ancient A) is largely restricted to Southern Africa. Strains isolated in
the American continent belong mainly to A.Br. 009 (A.Br.WNA) in
North America and to A.Br.054 (A.Br.V770) in South America (Fig. 2).
In comparison, lineages B and C show limited distribution. C is only
detected in North America and B in Europe and South Africa (Van Ert
et al., 2007).
Cluster A.Br.010/008 is subdivided in three subclades: A.Br.054
(V770), A.Br.003/014 (Sterne/Ames subclade; further subdivided in
A.Br.075 [Sterne] and A.Br.081 [Ames]) and A.Br. 003/002 (Aust94)
(Fig. 2) (Sahl et al., 2016). A.Br.054 is broadly spread as it was found in
the American continent, Africa and Europe (Sahl et al., 2016). This
subclade includes attenuated strains produced in the USA in the ‘60s
(Wright et al., 1962). A.Br.003/014 is thought to have origins in China
and subsequently spread across the world (Simonson et al., 2009). This
subclade is found in Asia, the American continent and in Europe (Sahl
et al., 2016; Van Ert et al., 2007). A.Br.003/002 is present on all con-
tinents (Khmaladze et al., 2014; Van Ert et al., 2007). Subclade
A.Br.TEA of the branch A is further divided in A.Br.008/011 (A.Br.TEA
Br.008/011), A.Br.WNA. and A.Br.011/009 (TEA Br.011) (Figs. 2 and
3) (Marston et al., 2011; Sahl et al., 2016). A.Br.TEA is highly
branching with several direct descendant subclades (Fig. 2) and with
generally only few SNPs developing between branches (Sahl et al.,
2016; Vergnaud et al., 2016).
A.Br.WNA. is found largely in North America (Figs. 2 and 3). It was
used to argue for an ungulate transmission model with an estimated
infection/death/year rate of 0.28 generations per year, based on a study
of 13 consecutive anthrax outbreaks in cattle in northern Canada be-
tween 1962 and 1991 (Dragon and Elkin, 2001; Keneﬁc et al., 2009).
Analysis of a large number of B. anthracis strains with precise geo-
graphical data of isolation led to estimate the dispersion of clade A
reaching the Northern American continent in the late Pleistocene
epoch, about 13′000 years ago via the former Bering Land Bridge (that
was cleared later on by receding glaciers) and progressing as subclade
A.Br.WNA from the Northwest Territories and Alberta, Canada, south-
wards to the southern states of USA and to California (Keneﬁc et al.,
2009). Subsequently, the inclusion of whole genome sequences of
European and African A.Br.TEA strains showed a common origin of
A.Br.WNA and French A.Br.TEA strains that caused the authors to hy-
pothesize about a much more recent split about 500 years ago (Girault,
2015; Vergnaud et al., 2016) (Fig. 3). Based on these assumptions the
authors proposed an alternative model of dissemination of A.Br.WNA to
North America, due to Breton explorers and emigrants from Northern
France (Jacques Cartier 1541, Samuel de Champlain 1608) that reached
the Gulf of St. Lawrence and settled along the St. Lawrence River
founding the cities of Quebec and Montréal (Girault, 2015; Vergnaud
et al., 2016). Although it is known that explorers and settlers brought
along their animals with their chattels and might have disseminated
anthrax by contaminated animals, there is currently no evidence of
anthrax being ecologically established in this area, which would argu-
ment against this hypothesis. Furthermore, an introduction of subclade
A.Br.WNA into South-Eastern Canada is not consistent with the phy-
logenetic pattern of B. anthracis strains from Northern America as the
most basal A.Br.WNA subclade strains were isolated in the North-West
of the continent (Keneﬁc et al., 2009; Vergnaud et al., 2016). The
nearest relationship of strains isolated from Western Africa to French
strains of TEA (but also to Italian strains (Sahl et al., 2016) (Fig. 3) was
taken as argument that migrants of North France moving to Western
Africa, at about the same time as migration to South-Eastern Canada,
might have disseminated anthrax to Senegal and today's The Gambia
(Girault, 2015; Vergnaud et al., 2016). The disagreement in timing
between the models of Keneﬁc and collaborators (Keneﬁc et al., 2009;
Vergnaud et al., 2016) and that of Girault and Vergnaud (Girault, 2015;
Vergnaud et al., 2016) seems be due to the fact that the latter used
relatively short branches of the phylogeny of French B. anthracis TEA
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strains as a basis for their timing. This assumes that longer branches, as
were described for A.Br.WNA. strains (Keneﬁc et al., 2009; Vergnaud
et al., 2016), would represent accelerated evolution. However, recent
work on evolutionary timing indicates that branch lengths are not
adequate for the determination of timing of divergence of the diﬀerent
clades and subclades (Sahl et al., 2016). In particular, short branches
and polytomies at critical positions in the phylogenic structure are
prone to blur the determination of evolutionary timing (Sahl et al.,
2016).
Clade B represents around 10% of the strains analyzed worldwide
(Sahl et al., 2016). This lineage shows a limited geographical dis-
tribution and is divided in two subclades: B.Br.CNEVA (B.Br.004) and
B.Br.001/002 (B.Br.002) (Derzelle et al., 2016b; Sahl et al., 2016; Van
Ert et al., 2007). B.Br.CNEVA is found in Europe only and coexists with
strains belonging to the clade A resulting in two overlapping clades in
Europe (Derzelle et al., 2011; Garofolo et al., 2011; Gierczynski et al.,
2009; Pilo et al., 2008; Van Ert et al., 2007). Clades A and B initially
showed a long common history before the ﬁrst bifurcation is observed
within each clade separating B.Br.001/002 from B.Br.CNEVA and se-
paration of clade A.Br.005/006 from the rest of clade A (Fig. 3). These
divergences were estimated to have occured about the time of the
emergence of agriculture and farming in the Fertile Crescent region and
subsequent human migrations early farmers into Europa over the fol-
lowing millenniums (Derzelle et al., 2016b). In contrast to clade A,
which spread around the world facilitated strongly by international
trade of animal hair and skin products, strains from B.Br.CNEVA have
only been reported from France, Southern Germany, Switzerland,
Northern Italy, Bosnia and Herzegovina, Croatia, Slovenia, Slovakia and
Poland (Girault, 2015; Vergnaud et al., 2016). This represents a trans-
alpine axis constituted by pastoral valleys with rich grassland where
cattle breeding might have provided a favorable environment for spore
survival and host-propagation of B. anthracis. As depicted in Fig. 3, sub-
clustering of strains of B.Br.CNEVA are concordant with geographical
patterns (Derzelle et al., 2016b; Derzelle et al., 2011; Girault et al.,
2014). These latter strongly correspond to speciﬁc cattle breeds that
were kept isolated in these locations over many centuries (Derzelle
et al., 2016b; Derzelle et al., 2011; Girault et al., 2014). Main breeds of
speciﬁc areas are: in Saône et Loire: Charolaise, in the French Massif
Central: Limousine, in French Alps: Tarantaise and Abondance, in
French Pyrenees: Cascogne and Lourdais, in Western Switzerland:
Simmental and in Eastern Switzerland Swiss Brown. All these cattle
breeds were kept traditionally and considered as local heritage for
centuries and were not exchanged. This geographic isolation might
have contributed to the genetic diversity observed among B.Br.CNEVA
(Derzelle et al., 2016b). This is in strong contrast to strains of clade A,
which in Europe do not correlate to areas with speciﬁc cattle breeds.
Hence, strains of clade B might be older in Europe than clade A strains
assumingly spread later on by international trade. Subcluster B.Br.001/
002 is ecologically established in South Africa and might have been
brought by early settlers (Smith et al., 2000).
Clade C seems to occur extremely infrequently since only three
strains from North America were isolated and analyzed up to present
(Sahl et al., 2016; Van Ert et al., 2007).
6. Forensic applications
Beyond the information gained at the level of geographical dis-
tribution of strains and evolution of B. anthracis, the molecular tools
developed to analyze intraspecies diversity proved valuable for forensic
investigations, even retrospectively. In these cases, molecular analyses
provided essential information to solve unanswered investigative
questions. 1) the anthrax sugar lumps from 1917 (Antwerpen et al.,
2017), 2) the Sverdlovsk outbreak in 1979 (Sahl et al., 2016), 3) the
Kameido incident in 1993 (Takahashi et al., 2004), 4) the Amerithrax
attack (Rasko et al., 2011) and 5) the outbreaks of injectional anthrax
(IA) (Keim et al., 2015).
The ﬁrst example dates from the First World War. A German spy, the
Baron Otto von Rosen, was arrested in Norway in 1917 for suspicion of
espionage and sabotage in possession of sugar lumps containing B.
anthracis (Redmond et al., 1998). The lumps were deposited afterwards
at the police museum in Trondheim, Norway. In 1997, they were sent to
the Defence Evaluation Research Agency, Chemical and Biological De-
fence, in Porton Down, UK, for analysis (Antwerpen et al., 2017;
Redmond et al., 1998). After sub-culturing and enrichment eﬀorts, four
colonies, phenotypically consistent with B. anthracis, were recovered
(Redmond et al., 1998). Subsequent genomic analyses showed that the
colonies isolated from the samples belong to the subcluster A.Br.Ames
and that they have the same MLVA proﬁle than the strain Ames
Fig. 3. Schematic tree summarizing the latest
data on phylogeography of worldwide B. an-
thracis strains.
The diﬀerent canSNP groups are shown in diﬀerent
colors. The three major clades A, B and C are in-
dicated by the ﬁrst capital letter of the designation of
the major canSNP groups. The large clade A is re-
presented on the right and lower part of the ﬁgure.
Clade B is on the upper left part and the small clade C
is in black in the middle. Branch lengths are not
scaled. The geographic locations of the French and
Swiss sub-groups of clade B are speciﬁcally given to
illustrate the narrow geographic clustering. Data are
compiled from (Derzelle et al., 2016a, 2016b;
Derzelle et al., 2011; Girault, 2015; Girault et al.,
2014; Vergnaud et al., 2016).
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Ancestor. Additionally, in silico analysis of genomes revealed only two
nonsynonymous SNPs with strain Ames Ancestor (Antwerpen et al.,
2017). Since this strain was isolated from a cow in the USA in 1981 and
it is a common laboratory strain, the colonies isolated from the sample
of the Trondheim police museum were considered to be laboratory
contaminations (Ravel et al., 2009).
The following example resulted in one of the larger outbreaks of
inhalational anthrax, aﬀecting humans and animals, that occurred in
1979 in Sverdlovsk, former USSR (today Jekaterinburg) (Abramova
et al., 1993; Meselson et al., 1994). This epidemic raised the suspicion
of an accidental release of B. anthracis spores from a military site. In
former USSR, the event was ﬁrst reported as an outbreak of gastro-
intestinal anthrax caused by naturally contaminated meat form dis-
eased animals that were slaughtered in the adjacent rural area
(Meselson et al., 1994). However, pathological evidence suggested
cases of inhalational anthrax (Abramova et al., 1993). The presence of
B. anthracis was later conﬁrmed by PCR in formalin-ﬁxed paraﬃn
embedded (FFPE) tissues of victims (Jackson et al., 1998). CanSNP
analysis assigned the sample to clade A.Br.008/009 (Okinaka et al.,
2008). Direct sequencing of FFPE samples originating from two patients
reﬁned the phylogenetic position of the infecting strain: A.Br.008/009
more precisely the TEA subclade A.Br.008/011 (Sahl et al., 2016). The
results position the Sverdlovsk strain in a clade comprising wild type
Eurasian strain, including two Asian live vaccine strains. The authors of
this study also examined the possibility of genetic manipulations but
did not ﬁnd evidence for this strain. Additionally, the similarity of the
Sverdlovsk strain to genomic sequences with wild type strains suggest
limited sub-culturing of the strain used (Sahl et al., 2016).
The third example is a case that occurred in Japan in late June 1993
(Sugishima, 2003). The Aum Shinrikyo tried to release spores of B.
anthracis from the roof of their headquarter in Tokyo. The event was
noticed because of “foul odors” in the neighborhood (Takahashi et al.,
2004). Despite dozens of complaints reporting loss of appetite, nausea,
and vomiting from residents, none of this cases developed human an-
thrax. A sample, collected at the site, was subsequently analyzed. After
isolation of B. anthracis colonies, the isolates were subjected to MLVA.
All isolates showed the same VNTRs proﬁle as strain Sterne (Sahl et al.,
2016; Sterne, 1939). This strain is widely used as a life vaccine in ve-
terinary medicine (Sterne, 1988). Both, strain Sterne and the isolates
from the intentional release in Tokyo lack plasmid pXO2 encoding for
the capsule. The fact that no anthrax cases were reported in this attack
is assumed to be related to the pXO2-deﬁcient life vaccine strain that
was released and that is known to be safe for cattle and hence seems not
to be virulent or of only low virulence to humans.
Following September 11, 2001, the US suﬀered attacks with spores
of B. anthracis sent in letters to two senators and several news agencies
via mail. At least 22 victims developed anthrax (11 cutaneous and 11
inhalational), among them, ﬁve died of pulmonary anthrax (Jernigan
et al., 2002; mailings, 2011). Using VNTR and SNP analysis the isolates
could be categorized as strain Ames (Hoﬀmaster et al., 2002). However,
the investigating scientists noticed colonies displaying minor morpho-
logical variations present from samples of the diﬀerent letters. The
same variants were present in all the letters. After full genome se-
quencing, they could attribute genomic diﬀerences to the diﬀerent
morphological types observed (Rasko et al., 2011). These genomic
signatures were unique enough to trace back the source of the spores to
a speciﬁc laboratory batch. These results conﬁrmed that the strain used
for the attacks was a laboratory strain and not a strain circulating in
natural settings.
The last example concerns a new form of anthrax that was recently
described. The ﬁrst death due to B. anthracis in an injectional heroin
drug user was reported in 2000 (Ringertz et al., 2000). Two outbreaks
of IA followed in 2009–2010 (UK, Germany) and in 2012–2013 (Den-
mark, France, Germany, UK), respectively (Berger et al., 2014). This
manifestation of the disease was of major concern because of the poor
clinical outcome (Booth et al., 2010; Hanczaruk et al., 2014; Powell
et al., 2011). Forensic investigations to determine the source of the
heroin contamination were extremely complicated because of the il-
legality related to heroin production, distribution and use (Team,
2011). Attempts to isolate strains from drug batches were unsuccessful
but some isolates could be retrieved from patients and submitted to
molecular analysis (Hanczaruk et al., 2014; Team, 2011). These strains
were shown to belong to the TEA lineage clustering with strains from
Turkey (Hanczaruk et al., 2014; Price et al., 2012). In a subsequent
study, Keim and colleagues fully sequenced 58 strains from 36 patients
to enhance the resolution of the typing (Keim et al., 2015). By screening
of 1293 isolates they could show that heroin contaminations occurred
during at least two events possibly during transportation via the Middle
East to Europe.
7. B. cereus non anthracis strains causing anthrax
In early 2000 an anthrax-like disease, in humans and animals,
caused by non-B. anthracis strains was described (Antonation et al.,
2016; Hoﬀmaster et al., 2006; Hoﬀmaster et al., 2004; Klee et al., 2010;
Klee et al., 2006; Leendertz et al., 2004; Leendertz et al., 2006; Marston
et al., 2016; Pilo et al., 2011; Wright et al., 2011). The strains exhibited
a combination of phenotypic traits of B. anthracis and B. cereus and were
named B. cereus biovar anthracis (Table 1) (Antonation et al., 2016;
Hoﬀmaster et al., 2006; Hoﬀmaster et al., 2004; Klee et al., 2006; Pilo
et al., 2011). Interestingly, the strains from the USA were isolated from
humans, while the strains isolated in Africa were from animals
(Antonation et al., 2016; Hoﬀmaster et al., 2006; Hoﬀmaster et al.,
2004; Klee et al., 2010; Klee et al., 2006; Leendertz et al., 2004;
Leendertz et al., 2006; Marston et al., 2016; Pilo et al., 2011; Wright
et al., 2011). B. cereus biovar anthracis from Africa were shown to
Table 1
Phenotypic traits of B. cereus non anthracis strains causing anthrax.
Phenotype Strain
G9241 03BB87 03BB102 BcFL2013 03BB108 Elc2 CA CI RCA A-363/2 DRC 14-0024-
1
JF3964
Hemolysis + + + + + + − − − − −
Motility + + + ND + + + + + − ND
Gamma phage R R R R R ND R R R R R
Capsule + + + + − + + + +a +a +a
Penicillin S ND ND ND ND Rb R S R R R
Published in Hoﬀmaster
et al., 2004
Hoﬀmaster
et al., 2006
Hoﬀmaster
et al., 2006
Marston
et al., 2016
Hoﬀmaster
et al., 2006
Wright
et al.,
2011
Klee
et al.,
2006
Klee
et al.,
2006
Antonation
et al., 2016
Antonation
et al., 2016
Pilo
et al.,
2011
R: resistant; S: sensitive; ND: not determined.
a Suspected because of mucoid appearance of colonies.
b Tested only for ampicillin and ceftriaxone resistance.
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harbor plasmids similar to pXO1 and pXO2 that are positive by PCR for
the respective virulence gene markers of these plasmids (Antonation
et al., 2016; Klee et al., 2010; Pilo et al., 2011). In contrast, American
strains seem to have a pXO1-like plasmid but not a pXO2-like plasmid
(Hoﬀmaster et al., 2006; Hoﬀmaster et al., 2004; Marston et al., 2016;
Wright et al., 2011). Instead, they possess a second plasmid pBC218,
which carries the bpsX-H operon encoding for another polysaccharide
capsule but does not harbor the capBCDAE genes that encode for the
poly-γ-D-glutamic acid capsule (Hoﬀmaster et al., 2004); (Hoﬀmaster
et al., 2006; Oh et al., 2011). This is conﬁrmed phenotypically as
American strains do not react with antibodies directed against the poly-
γ-D-glutamic acid capsule of B. anthracis (Sue et al., 2006). The pXO1-
like plasmid pBCXO1 contains the genes hasABC encoding for the bio-
synthesis of a hyaluronic acid capsule and the toxin genes pagA1, lef1,
cya1 (Oh et al., 2011). An inactive hasACB operon is also present in the
pXO1 plasmid of B. anthracis. It is not expressed, due to the presence of
a single mutation (Oh et al., 2011; Okinaka et al., 1999). B. cereus strain
G9241 contains plasmid pBCXO1 with the toxin genes, as well as ha-
sACB, providing for hyaluronic acid capsule formation plus plasmid
pBC218 harboring the operon bpsX-H, specifying the B. cereus exo-
polysaccharide, which produce a second capsule. During infection, B.
cereus G9241 both hasACB and bpsX-H capsules are essential for the
establishment of anthrax-like disease and resistance to phagocytosis. In
contrast, African B. cereus biovar anthracis strains produce a poly-γ-D-
glutamic acid capsule since they carry a pXO2-like plasmid (Antonation
et al., 2016; Klee et al., 2006). They also synthetize the hyaluronic acid
capsule (Brezillon et al., 2015). Remarkably, curing of the pXO2-like
plasmid in these strains did not signiﬁcantly alter their virulence in
mice and guinea pigs (Brezillon et al., 2015). This is a contrasting
ﬁnding compared to B. anthracis in which the loss of pXO2 results in
substantial attenuation (Harvill et al., 2005). These ﬁndings conﬁrm
that the presence of a functional hasACB operon providing the hya-
luronic acid capsule enables these strains of B. cereus biovar anthracis to
have full virulence in mammals (Brezillon et al., 2015; Oh et al., 2011).
While B. anthracis is largely limited to arid ecosystems where outbreaks
occur mostly in bovine species, anthrax-causing Bacillus cereus biovar
anthracis in Africa is widely present and persistent in tropical rainforest
where it is responsible for causing death to a wide range of mammalian
hosts and constitutes a particular threat to local chimpanzee popula-
tions (Hoﬀmann et al., 2017).
8. Conclusion
New biochemical and molecular biological data on the binary an-
thrax toxins reveal their high potency and high speciﬁcity to receptors
of the capillary morphogenesis genes 2 product (CMG2) and the tumor
endothelial marker 8 (TEM8) by means of the adhesive and transloca-
tion subunit, the protective antigen PA. Immune cells are the most
heavily targeted cells by the lethal toxin LT. By subversion of the cel-
lular compartments, the lethal toxin is able to persist for long periods in
intra-luminal vesicles and thus insuring the pathogen an ideal en-
vironment to spread its eﬀects to disabled cells. This explains the par-
ticular virulence of the anthrax toxins and the unconditional adminis-
tration of rapid therapy of infected individuals. Based on full genome
sequencing of many strains of B. anthracis and analysis of single nu-
cleotide polymorphisms, the dissemination of anthrax could be traced
back to early origins and shows the important role of domestication of
animals, human migration and international trade of animal products
as the cause of the worldwide spread of anthrax. While whole genome
sequencing results in detailed and robust clade structures of B. an-
thracis, temporal predictions of speciﬁc events remain critical in spite of
large data sets from high-throughput sequencing. A still rarely reported
type of anthrax caused by strains of B. cereus biovar anthracis in Africa
has its proper epidemiology in inhabited areas of tropical rainforests,
where it threatens primate populations. The new whole genome se-
quencing techniques and potent bioinformatics represent powerful
means to analyze large numbers of strains in order to unravel epidemics
and to implement measures to protect humans, livestock and wildlife
populations.
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